NCT00240773View on ClinicalTrials.gov

A Safety and Effectiveness Study of Acetaminophen (4000 mg/Day) and Naproxen (750 mg/Day) in the Treatment of Osteoarthritis of the Hip or Knee

PHASE3CompletedINTERVENTIONAL
Enrollment

581

Participants

Timeline

Start Date

Not specified

Study Completion Date

June 30, 2003

Conditions
Osteoarthritis, HipOsteoarthritis, Knee
Interventions
DRUG

acetaminophen

4 grams daily for six months

DRUG

naproxen

750 mg daily for 12 months

DRUG

acetaminophen

4 grams daily for 12 months

DRUG

naproxen

750 mg daily for six months

All Listed Sponsors
collaborator

McNeil Consumer & Specialty Pharmaceuticals, a Division of McNeil-PPC, Inc.

INDUSTRY

lead

Johnson & Johnson Consumer and Personal Products Worldwide

INDUSTRY

NCT00240773 - A Safety and Effectiveness Study of Acetaminophen (4000 mg/Day) and Naproxen (750 mg/Day) in the Treatment of Osteoarthritis of the Hip or Knee | Biotech Hunter | Biotech Hunter